APA (7th ed.) Citation

Stirrup, O., Asboe, D., Pozniak, A., Sabin, C., Gilson, R., Mackie, N., . . . Gunson, R. (2020). Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation. HIV Medicine, 21(5), 309. https://doi.org/10.1111/hiv.12829

Chicago Style (17th ed.) Citation

Stirrup, OT, et al. "Continuation of Emtricitabine/lamivudine Within Combination Antiretroviral Therapy Following Detection of the M184V/I HIV‐1 Resistance Mutation." HIV Medicine 21, no. 5 (2020): 309. https://doi.org/10.1111/hiv.12829.

MLA (9th ed.) Citation

Stirrup, OT, et al. "Continuation of Emtricitabine/lamivudine Within Combination Antiretroviral Therapy Following Detection of the M184V/I HIV‐1 Resistance Mutation." HIV Medicine, vol. 21, no. 5, 2020, p. 309, https://doi.org/10.1111/hiv.12829.